ArticleAnimal microbiome2026
Gut microbiota remodeling by Astragalus membranaceus stems and leaves correlates dual modulation of arachidonic acid and tryptophan metabolism to counteract perinatal stress-induced hemometabolic dysregulation in sows.
Article in Animal microbiome, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Perinatal stress (PS) commonly occurring in high-yielding sows has gradually become a factor threatening the reproductive and immunoreactive performances by impairing their fecundity. Despite the Astragalus membranaceus, a herb native to northern China, has been applied to relieve PS, it is still unclear whether its aerial parts, i.e., Astragalus membranaceus stems and leaves (AMSL), protects against reproductive damage induced by PS in sows and how it works. Here, we aims to evaluate the novel roles of AMSL in alleviating PS-induced reproductive disorders in sows (n = 45) and their offsprings (n = 45). Amplicon-based microbiota analysis revealed that maternal dietary supplementation of AMSL significantly induced affluent Prevotella, Limosilactobacillus, Rikenellaceae_RC9_gut_group, and Clostridium_sensu_sticto_1 in perinatal sows and was correlated with accelerated maturation of gut microbiota in preweaning piglets. Untargeted metabolomics were used to profile serum and fecal metabolites, and serum arachidonic acid (AA)-related metabolites were markedly diminished on the day of farrowing and from neonatal piglets at birth post AMSL administration in sows. Pearson correlation analyses indicated that enriched indole-related metabolites and fewer kynurenine-related metabolites were strongly positively correlated with these four bacteria. Then, fecal microbiota transplantation (FMT) in pregnant mice were conducted to illustrate whether the protective role of AMSL is mediated by remodeling gut microbiota. PS and immunosuppressive symptoms were both largely ameliorated in mice that had received fecal bacteria of sows pretreated with AMSL. These results support the notion that the beneficial effects of AMSL were primarily achieved via gut microbiota modulation, which related to improved tryptophan metabolism and inhibited the excessive synthesis of AA in blood circulation. Our findings provide new insights into the potential application of AMSL as a sustainable feed additive.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.